| For: | Scaldaferri F, Lancellotti S, Pizzoferrato M, Cristofaro RD. Haemostatic system in inflammatory bowel diseases: New players in gut inflammation. World J Gastroenterol 2011; 17(5): 594-608 [PMID: 21350708 DOI: 10.3748/wjg.v17.i5.594] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i5/594.htm |
| Number | Citing Articles |
| 1 |
Peter D.R. Higgins, Martha Skup, Parvez M. Mulani, Jay Lin, Jingdong Chao. Increased Risk of Venous Thromboembolic Events With Corticosteroid vs Biologic Therapy for Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology 2015; 13(2) doi: 10.1016/j.cgh.2014.07.017
|
| 2 |
Wang Jingjie, Shen Jun. Gut vascular barrier in the pathogenesis and resolution of Crohn's disease: A novel link from origination to therapy. Clinical Immunology 2023; 253 doi: 10.1016/j.clim.2023.109683
|
| 3 |
Mi Ja Park, Jong Hoon Won, Dae Kyong Kim. Thrombin Induced Apoptosis through Calcium-Mediated Activation of Cytosolic Phospholipase A2 in Intestinal Myofibroblasts. Biomolecules & Therapeutics 2023; 31(1) doi: 10.4062/biomolther.2022.043
|
| 4 |
Beatriz Marcos-Ramiro, Diego García-Weber, Susana Barroso, Jorge Feito, María C. Ortega, Eva Cernuda-Morollón, Natalia Reglero-Real, Laura Fernández-Martín, Maria C. Durán, Miguel A. Alonso, Isabel Correas, Susan Cox, Anne J. Ridley, Jaime Millán. RhoB controls endothelial barrier recovery by inhibiting Rac1 trafficking to the cell border. Journal of Cell Biology 2016; 213(3) doi: 10.1083/jcb.201504038
|
| 5 |
Naïk Vietti Violi, Alain M. Schoepfer, Nicolas Fournier, Boris Guiu, Pierre Bize, Alban Denys. Prevalence and Clinical Importance of Mesenteric Venous Thrombosis in the Swiss Inflammatory Bowel Disease Cohort. American Journal of Roentgenology 2014; 203(1) doi: 10.2214/AJR.13.12447
|
| 6 |
Stanko Petrovic, Slobodan Obradovic, Marijana Petrovic, Nemanja Rancic. Ulcerative Colitis - Etiology, Diagnosis, Diet, Special Populations, and the Role of Interventional Endoscopy. 2022; doi: 10.5772/intechopen.102041
|
| 7 |
Meshal Almalki, Camilla R. De Pierri, Tristan Méric, Héla Mkaouar, Donia Slimani, Vincent Mariaule, Sirine Tebassi, Nizar Akermi, Emmanuelle Maguin, Juan Hernandez, Roberto T. Raittz, Moez Rhimi, Francesco Asnicar. Protease-serpin-microbiome interactions in inflammatory bowel disease: toward integrated biomarkers of gut health. Gut Microbes 2026; 18(1) doi: 10.1080/19490976.2026.2726641
|
| 8 |
Petros Zezos, Georgios Kouklakis, Fred Saibil. Inflammatory bowel disease and thromboembolism. World Journal of Gastroenterology 2014; 20(38): 13863-13878 doi: 10.3748/wjg.v20.i38.13863
|
| 9 |
Antonietta Gerarda Gravina, Marcello Dallio, Mario Masarone, Valerio Rosato, Andrea Aglitti, Marcello Persico, Carmelina Loguercio, Alessandro Federico, Saeid Golbidi. Vascular Endothelial Dysfunction in Inflammatory Bowel Diseases: Pharmacological and Nonpharmacological Targets. Oxidative Medicine and Cellular Longevity 2018; 2018(1) doi: 10.1155/2018/2568569
|
| 10 |
Wael Mami, Soumaya Znaidi-Marzouki, Raoudha Doghri, Melika Ben Ahmed, Sadri Znaidi, Erij Messadi. Inflammatory Bowel Disease Increases the Severity of Myocardial Infarction after Acute Ischemia–Reperfusion Injury in Mice. Biomedicines 2023; 11(11) doi: 10.3390/biomedicines11112945
|
| 11 |
Diana-Maria Bunu, Cristian-Eugen Timofte, Manuela Ciocoiu, Mariana Floria, Claudia-Cristina Tarniceriu, Oana-Bogdana Barboi, Daniela-Maria Tanase. Cardiovascular Manifestations of Inflammatory Bowel Disease: Pathogenesis, Diagnosis, and Preventive Strategies. Gastroenterology Research and Practice 2019; 2019 doi: 10.1155/2019/3012509
|
| 12 |
Extraintestinal manifestations of inflammatory bowel disease, nitroxidative stress and dysbiosis: What is the link between them?. BIOCELL 2021; 45(3) doi: 10.32604/biocell.2021.014332
|
| 13 |
Beatriz Vieira Neto, Valéria Tavares, Joana M. O. Santos, Fátima Cerqueira, Deolinda Pereira, Rui Medeiros. Map of thrombogenesis in viral infections and viral-driven tumours. Discover Oncology 2023; 14(1) doi: 10.1007/s12672-022-00610-1
|
| 14 |
Werner Schmid, Harald Vogelsang, Pavol Papay, Christian Primas, Alexander Eser, Cornelia Gratzer, Michael Handler, Gottfried Novacek, Simon Panzer. Increased responsiveness to thrombin through protease-activated receptors (PAR)-1 and -4 in active Crohn's disease. Journal of Crohn's and Colitis 2014; 8(6) doi: 10.1016/j.crohns.2013.11.001
|
| 15 |
O. V. Khlynova, E. A. Stepina. Specific Features of Vascular Endothelium in Patients with Severe Forms of Inflammatory Bowel Diseases. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2018; 28(5) doi: 10.22416/1382-4376-2018-28-5-98-104
|
| 16 |
Nour M. Moukalled, Jana G. Hashash, Ali T. Taher. Inflammatory Bowel Disease: An Indication to Screen for Thrombophilia?. Diseases 2022; 10(1) doi: 10.3390/diseases10010014
|
| 17 |
Umang Jain, Anthony R. Otley, Johan Van Limbergen, Andrew W. Stadnyk. The Complement System in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2014; 20(9) doi: 10.1097/MIB.0000000000000056
|
| 18 |
Victoria P Tan, Alvin Chung, Bryan P Yan, Peter R Gibson. Venous and arterial disease in inflammatory bowel disease. Journal of Gastroenterology and Hepatology 2013; 28(7) doi: 10.1111/jgh.12260
|
| 19 |
Sofija I. Lugonja, Ivana L. Pantic, Tamara M. Milovanovic, Vesna M. Grbovic, Bojana M. Djokovic, Željko D. Todorovic, Stefan M. Simovic, Raša H. Medovic, Nebojsa D. Zdravkovic, Natasa D. Zdravkovic. Atherosclerotic Cardiovascular Disease in Inflammatory Bowel Disease: The Role of Chronic Inflammation and Platelet Aggregation. Medicina 2023; 59(3) doi: 10.3390/medicina59030554
|
| 20 |
Jean-Paul Motta, Simone Palese, Carmine Giorgio, Kevin Chapman, Alexandre Denadai-Souza, Perrine Rousset, David Sagnat, Laura Guiraud, Anissa Edir, Carine Seguy, Laurent Alric, Delphine Bonnet, Barbara Bournet, Louis Buscail, Cyrielle Gilletta, Andre G Buret, John L Wallace, Morley D Hollenberg, Eric Oswald, Elisabetta Barocelli, Sylvie Le Grand, Bruno Le Grand, Celine Deraison, Nathalie Vergnolle. Increased Mucosal Thrombin is Associated with Crohn’s Disease and Causes Inflammatory Damage through Protease-activated Receptors Activation. Journal of Crohn's and Colitis 2021; 15(5) doi: 10.1093/ecco-jcc/jjaa229
|
| 21 |
Hasan Kayahan, Ismail Sari, Nesat Cullu, Fahize Yuksel, Serdal Demir, Mesut Akarsu, Yigit Goktay, Belkis Unsal, Hale Akpinar. Evaluation of Early Atherosclerosis in Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences 2012; 57(8) doi: 10.1007/s10620-012-2148-x
|
| 22 |
Imen Kraiem, Samira Hadhri, Mohamed Ben Rejeb, Lamia Ifa, Ali Jmaa, Salem Ajmi, Hadef Skouri. Antiphospholipid Antibodies and Procoagulant Profile in Tunisians With Inflammatory Bowel Diseases. Clinical and Applied Thrombosis/Hemostasis 2016; 22(8) doi: 10.1177/1076029615581364
|
| 23 |
Su Xu, Zhao‑Xiu Xu, Shuai Yan, Jin Le, Hao Chen, Lan Ming, Shu‑Guang Xu, Tao Lin. Curcumin suppresses intestinal microvascular endothelial cells invasion and angiogenesis induced by activated platelets. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7662
|
| 24 |
G. B. Bikbavova, M. A. Livzan. Cardiovascular risks in patients with inflammatory bowel disease: what should be taken into account?. Experimental and Clinical Gastroenterology 2021; 1(6) doi: 10.31146/1682-8658-ecg-190-6-112-120
|
| 25 |
Shoji Kasai, Hidenori Karasaki, Atsuo Maemoto, Shigeru Furukawa, Takahiro Itou, Toru Kono. Acute Infectious Purpura Fulminans Caused by Citrobacter Freundii Sepsis in a Patient with Crohn's Disease. Nippon Daicho Komonbyo Gakkai Zasshi 2018; 71(2) doi: 10.3862/jcoloproctology.71.91
|
| 26 |
|
| 27 |
Jermilia Charles, Victoria A. Ploplis. COVID-19 Induces Cytokine Storm and Dysfunctional Hemostasis. Current Drug Targets 2022; 23(17) doi: 10.2174/1389450124666221025102929
|
| 28 |
Hirushi Kumarapperuma, Ran Wang, Peter J Little, Danielle Kamato. Mechanistic insight: Linking cardiovascular complications of inflammatory bowel disease. Trends in Cardiovascular Medicine 2024; 34(3) doi: 10.1016/j.tcm.2023.01.002
|
| 29 |
Ping Wu, Fangyuan Jia, Bao Zhang, Peiying Zhang. Risk of cardiovascular disease in inflammatory bowel disease. Experimental and Therapeutic Medicine 2017; 13(2) doi: 10.3892/etm.2016.3966
|
| 30 |
Monika Merker, Susann Eichler, Alexander M. Herrmann, Heinz Wiendl, Christoph Kleinschnitz, Kerstin Göbel, Sven G. Meuth. Rivaroxaban ameliorates disease course in an animal model of multiple sclerosis. Journal of Neuroimmunology 2017; 313 doi: 10.1016/j.jneuroim.2017.08.013
|
| 31 |
Alicja Derkacz, Pawel Olczyk, Katarzyna Komosinska-Vassev. Diagnostic Markers for Nonspecific Inflammatory Bowel Diseases. Disease Markers 2018; 2018 doi: 10.1155/2018/7451946
|
| 32 |
Adarsh Ray, Krushna Ch. Maharana, Sarasa Meenakshi, Sanjiv Singh. Endothelial dysfunction and its relation in different disorders: Recent update. Health Sciences Review 2023; 7 doi: 10.1016/j.hsr.2023.100084
|
| 33 |
Tatjana Ruskovska, Marika Massaro, Maria Annunziata Carluccio, Anna Arola-Arnal, Begoña Muguerza, Wim Vanden Berghe, Ken Declerck, Francisca Isabel Bravo, Nadia Calabriso, Emilie Combet, Eileen R. Gibney, Andreia Gomes, Marie-Paule Gonthier, Elena Kistanova, Irena Krga, Pedro Mena, Christine Morand, Claudia Nunes dos Santos, Sonia de Pascual-Teresa, Ana Rodriguez-Mateos, Egeria Scoditti, Manuel Suárez, Dragan Milenkovic. Systematic bioinformatic analysis of nutrigenomic data of flavanols in cell models of cardiometabolic disease. Food & Function 2020; 11(6) doi: 10.1039/D0FO00701C
|
| 34 |
Dorota Cibor, Renata Domagala-Rodacka, Tomasz Rodacki, Artur Jurczyszyn, Tomasz Mach, Danuta Owczarek. Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications. World Journal of Gastroenterology 2016; 22(3): 1067-1077 doi: 10.3748/wjg.v22.i3.1067
|
| 35 |
Andreas Katsanos, Ioannis Asproudis, Konstantinos H. Katsanos, Anna I. Dastiridou, Miltiadis Aspiotis, Epameinondas V. Tsianos. Orbital and optic nerve complications of inflammatory bowel disease. Journal of Crohn's and Colitis 2013; 7(9) doi: 10.1016/j.crohns.2012.09.020
|
| 36 |
Michael Pezold, Matthew Pergamo, Caron Rockman, Joanelle Lugo. Presentation and Management of Arterial Thromboembolisms during Active Inflammatory Bowel Disease: Case Series and Literature Review. Annals of Vascular Surgery 2020; 67 doi: 10.1016/j.avsg.2020.02.025
|
| 37 |
Zhonghua Hong, Ruyun Cai, Jiawei Wang, Hezhai Yin. Exploration of the protective mechanism of peony decoction on DSS-induced NCM460 cell injury based on network pharmacology and in vitro validation. Letters in Drug Design & Discovery 2026; doi: 10.1016/j.lddd.2026.100567
|
| 38 |
研 赵. Research on the Mechanism of Hypercoagulability in Inflammatory Bowel Disease. Advances in Clinical Medicine 2024; 14(08) doi: 10.12677/acm.2024.1482206
|
| 39 |
Tayfun Çinleti, Özlem Bağ, Çiğdem Ö Ecevit. Is Mean Platelet Volume a Useful Noninvasive Biomarker for Inflammatory Bowel Disease in Childhood?
. The Journal of Medical Sciences 2021; 6(1) doi: 10.5005/jp-journals-10045-00141
|
| 40 |
Jane Yu, Lara Boland, Melissa Catt, Leah Puk, Nadia Wong, Mark Krockenberger, Peter Bennett, Craig Ruaux, Valerie C. Wasinger. Serum proteome profiles in cats with chronic enteropathies. Journal of Veterinary Internal Medicine 2023; 37(4) doi: 10.1111/jvim.16743
|
| 41 |
Zubin Arora, Xianrui Wu, Udayakumar Navaneethan, Bo Shen. Non-surgical porto-mesenteric vein thrombosis is associated with worse long-term outcomes in inflammatory bowel diseases. Gastroenterology Report 2016; 4(3) doi: 10.1093/gastro/gov012
|
| 42 |
Martina Giannotta, Gherardo Tapete, Giacomo Emmi, Elena Silvestri, Monica Milla. Thrombosis in inflammatory bowel diseases: what’s the link?. Thrombosis Journal 2015; 13(1) doi: 10.1186/s12959-015-0044-2
|